Zhong Lun Served Huakang Biomedical Holdings Company Limited’s Listing on GEM of HKEX
Zhong Lun Served Huakang Biomedical Holdings Company Limited’s Listing on GEM of HKEX
On December 13, 2018, HUAKANG BIOMED (stock code: 08622.HK) listed on GEM of the Stock Exchange of Hong Kong Limited, and Zhong Lun Law Firm had provided legal services in this offering. Partner Jessical Li, supported by associates Weixiang Huang, Xiaolei Yuan, Congxin Chen and Shiyi Feng, served as HUAKANG BIOMED’s the PRC legal counsel, while Partner Victor Pang, supported by Shirley Chan, Benson Yee, acted as the Hong Kong legal counsel.
HUAKANG BIOMED is a medical device group specializing in the research and development, manufacture and sale of a wide range of IVD reagents in China.